Do haematological parameters such as HALP and Lymphocyte to C-reactive protein ratio predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer?
Polish Journal of Surgery · 2022-11-18 · 95 (3) · 21-29
DOI: 10.5604/01.3001.0016.0959 ↗Abstract
Aim: Inflammatory markers are effective in determining the prognosis of malignant diseases. The aim of this study is to investigate the relationship of HALP and LCR with tumor response after neoadjuvant chemoradiotherapy and their effects on prognosis in patients with locally advanced rectal cancer.
Methods: Eighty-eight patients who received nCRT with the diagnosis of LARC were included in the study. First, all patients were divided into 2 groups: patients with pathological and clinical complete response (pCR+cCR), group 1, and patients with non-complete response, group 2. The 82 patients who underwent surgery were divided into two groups according to the TRG Dworak: good response and poor response groups. Inflammation markers such as HALP and LCR were obtained using biochemical parameters.
Results: HALP and LCR were higher in the complete response group than in the none-complete response group (P
EUVIMED